Protagonist Therapeutics Inc (PTGX)

Protagonist Therapeutics Inc (PTGX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $9B; returns 1 day -0.8%, 1 week +7.5%, 1 year +87.1%.

Protagonist Therapeutics Inc. (PTGX) is a clinical-stage biopharmaceutical company focused on discovering and developing novel, orally administered, peptide-based therapies. Leveraging its proprietary Peptide 2.0 platform, the company aims to create drugs that offer the potency of biologics with the convenience of oral administration for diseases with significant unmet medical needs.

Groups PTGX belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage Biopharma
• Clinical Stage
• Healthcare
• Hematology
• Unmet Medical Needs
• Gastroenterology
• Dermatology
• Autoimmune Diseases
• Strategic Partnerships

PTGX financial model: income statement, cash flow and balance sheet